Light degrades tirzepatide
GLP-1 medications have been found to reduce inflammatory markers in the body, lowering the risk of developing metabolic syndrome-related diseases
New @NEJM study reveals #Semaglutide (#Ozempic) significantly reduces risks of major kidney events, cardiovascular outcomes, and mortality in patients with type 2 #diabetes and chronic kidney disease
In parallel, daily treatment with 50 g/kg liraglutide for 20 weeks improved urine chemistry and podocyte histology in Ins2 Akita mice, a transgenic model of spontaneous diabetes
In particular, several studies suggested that some anti-diabetic drugs could be of potential interest because of their anti-cancer effects demonstrated both in vitro and in vivo on TC
Here is how L-cysteine interacts with oxidative stress: Neutralising Free Radicals: L-cysteine, via glutathione production, influences free radicals